Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

Research on cancer therapies focuses on processes such as angiogenesis, cell signaling, stemness, metastasis, and drug resistance and inflammation, all of which are influenced by the cellular and molecular microenvironment of the tumor. Different strategies, such as antibodies, small chemicals, horm...

Full description

Bibliographic Details
Main Authors: Virginia Albiñana, Eunate Gallardo-Vara, Juan Casado-Vela, Lucía Recio-Poveda, Luisa María Botella, Angel M Cuesta
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
beta-adrenergic receptor antagonist
propranolol
chemotherapy
combination cancer therapy
HIF
apoptosis
Online Access:https://www.mdpi.com/2077-0383/11/15/4539

Similar Items

Similar Items